Switzerland’s Obseva eyes China re-start for fertility drug that failed trial
In November last year, ObsEva said it was scrapping a development programme for nolasiban to help women undergoing in-vitro…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.